With over 4,000 approved clinical trials currently being conducted in centres of medical excellence around the world, Terence Gregory, CEO of listed financial services group Ecsponent, says the field of regenerative medicine is exploding, hence the group's investment in Geneva-based biotechnology group, Salveo Swiss Technologies. 12 Jan 2015
The national Department of Health has announced the names of various pharmaceutical companies that have won the three year tender to supply antiretroviral (ARVs) to millions of patients on treatment in South Africa. 29 Dec 2014
The economic crisis has had a strong negative impact on drug consumption in Europe, despite an aging population. Governments, as the principal financers, have been forced to curb their health expenditure to contain the increase in their debt and have therefore limited the reimbursement of drugs. 9 Dec 2014
Only about half of all patients who are issued prescription medication that they must administer themselves actually take it as prescribed. Some do not properly follow the instructions for taking it, while many stop taking the medication all together. 21 Nov 2014
The acquisition of the Scientific Group's Diagnostics business by Ascendis will contribute immediate bottom-line benefit while simultaneously allowing the company to entrench its specialist product ranges and deliver organic growth benefits through integration synergies. 30 Oct 2014
Global Holdings Botswana, part of Imperial, has purchased a controlling interest in Fine Pharmaceuticals, a Botswana based pharmaceutical wholesaler. This acquisition is in line with Imperial's strategy to integrate pharmaceutical wholesaling into its service offering, in order to offer an unrivalled route to market proposition for clients in this sector. 13 Oct 2014
The International Generic Drug Regulators Pilot (IGDRP) is promoting the movement to permit pharmaceutical companies to register a product only once in the country of their choice, in order to market it elsewhere in the world. It could drastically improve access to more affordable quality generic medicines and in some cases even halve the selling price. 21 Aug 2014
Ascendis Health has acquired six leading products from Arctic Healthcare, in a deal valued at R151 million. These are Chela-Fer, Menacal7, Chela-Preg, Chela-Mag, Osteoflex and Supa Chewz. 12 Aug 2014
What is PIC/S, and why is it important for the quality of medicine production? 16 Jul 2014
The National Association of Pharmaceutical Manufacturers has announced its new exco. Taking over the reigns as the association's chairperson is Desmond Brothers, CEO of Ranbaxy, who will be assisted by the new vice-chairperson, Herman Grobler, COO of Cipla. 1 Jul 2014
L-R: Nchaupe Khaole (MIC), Mahlatse Kabi (MIC), Greg von Holdt (Director C2C), Mary Bomela (CEO MIC), Zaheer Abdulla (MIC), Sandile Lukhele (Director RHP), and Dimitri Clayton (RHP)
Ascendis Health announced last week that it has concluded an agreement with the Mineworkers Investment Company (MIC), which will see the BEE ownership in Ascendis increase over a three-year period. 1 Jul 2014
Aspen's Port Elizabeth manufacturing plant. The company says that earnings might be lower than expected in the second half after few government tenders were won. Image: Thembela Architects
Aspen Pharmacare is attempting to eliminate uncertainty regarding its second-half earnings by saying certain comments made by its management team at a conference call last week were misconstrued and taken out of context. 1 Jul 2014
The World Health Organization (WHO) estimates that 10-15% of the global drug supply is fake, in Africa, this may account for up to 30% of medicines in circulation - with these figures ever growing. 20 Jun 2014
Subject to the regulatory consent of the South African Competition Authorities, Ascendis Health has acquired Respiratory Care Africa, a specialist medical devices company, for R 145 million in a cash and shares deal. 17 Jun 2014
LONDON, UK: British pharmaceuticals giant GlaxoSmithKline has agreed to a US$350-million deal with Adaptimmune to help develop and sell the biotechnology firm's cancer drugs, the companies said on Monday, 2 June 2014. 3 Jun 2014
Had the Public Investment Corporation (PIC) not blown the Chilean pharmaceutical company CFR's bid for Adcock Ingram out of the water late last year, Adcock's shareholders would now have a huge return. 3 Jun 2014
AstraZeneca Pharmaceuticals, operational in 11 sub-Saharan African countries, has announced that it is launching into Zambia, initially focusing on providing cardiovascular, respiratory and gastrointestinal drugs and expanding its product portfolio to cover diseases like oncology and diabetes. 28 May 2014
Yale's Michael Kinch spent his spare time in the last year creating a massive database that encompasses the entire history of drug development in the United States. In a series of 20 articles scheduled to be published over the next year in the journal Drug Discovery Today, Kinch mines the data and provides historical tidbits about the history of drug development and reveals trends on how - or whether - we will get new medicines in the future. 29 Apr 2014
The Board of Adcock Ingram today, 3 April 2014, announced the appointment of Kevin Wakeford as chief executive officer, with immediate effect. Wakeford joins Adcock Ingram following more than 10 years' experience with the Bidvest Group Limited, where he led various companies within the group. 3 Apr 2014
Adcock's Jonathan Louw has quit the company with immediate effect. Image: Adcock
Jonathan Louw became the most high-profile casualty of the year-long battle that resulted in the Bidvest Group holding the single largest shareholding in drug maker Adcock Ingram. Louw quit as chief executive on Tuesday, 2 April 2014. 3 Apr 2014
Let's do Biz